CN1247211C - Health-care or medicinal tablet containing active ganoderma extract - Google Patents
Health-care or medicinal tablet containing active ganoderma extract Download PDFInfo
- Publication number
- CN1247211C CN1247211C CN 00112358 CN00112358A CN1247211C CN 1247211 C CN1247211 C CN 1247211C CN 00112358 CN00112358 CN 00112358 CN 00112358 A CN00112358 A CN 00112358A CN 1247211 C CN1247211 C CN 1247211C
- Authority
- CN
- China
- Prior art keywords
- ganoderma
- lamellar
- medicine
- health product
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000222336 Ganoderma Species 0.000 title claims abstract description 44
- 239000000284 extract Substances 0.000 title claims description 22
- 230000000694 effects Effects 0.000 claims abstract description 21
- 238000000855 fermentation Methods 0.000 claims abstract description 21
- 230000004151 fermentation Effects 0.000 claims abstract description 21
- 239000003814 drug Substances 0.000 claims abstract description 15
- 230000036541 health Effects 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract 2
- 239000000945 filler Substances 0.000 claims description 24
- 229920001491 Lentinan Polymers 0.000 claims description 15
- 229940115286 lentinan Drugs 0.000 claims description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- 239000000796 flavoring agent Substances 0.000 claims description 10
- 235000019634 flavors Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 6
- 229960002401 calcium lactate Drugs 0.000 claims description 6
- 235000011086 calcium lactate Nutrition 0.000 claims description 6
- 239000001527 calcium lactate Substances 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims 2
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 abstract description 17
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 239000007788 liquid Substances 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 9
- 230000000391 smoking effect Effects 0.000 abstract description 8
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 201000011510 cancer Diseases 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract 2
- 206010068956 Respiratory tract inflammation Diseases 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 description 19
- 239000003826 tablet Substances 0.000 description 19
- 238000002156 mixing Methods 0.000 description 18
- 230000036039 immunity Effects 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 239000006189 buccal tablet Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 208000028299 esophageal disease Diseases 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 208000018569 Respiratory Tract disease Diseases 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000000254 damaging effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000021953 cytokinesis Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 208000017572 squamous cell neoplasm Diseases 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 208000005440 Basal Cell Neoplasms Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- -1 triterpenoid compound Chemical class 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to the field of health products or medicines, particularly to various tablets prepared by taking ganoderma bacterium fermentation liquid (or whole powder) or a ganoderma active matter extracted from the liquid (or whole powder) as a raw material. The present invention is characterized in that the ganoderma bacterium fermentation liquid (or whole powder) or the ganoderma active matter extracted from the liquid (or whole powder) is taken as a raw material to be directly or matched with other components to be made into tablets, and through buccal taking or swallow, the purposes of phylactic power increase of users, aging resistance, harm effect relief of smoking to human bodies, tumor resistance, white cell increase of cancer patients and diseases cure, such as respiratory tract inflammation, etc. are achieved.
Description
The present invention relates to health product or medicine field, specifically a kind is the various tablets that feedstock production becomes with the ganoderma active thing, in order to improve immunity, defying age and to alleviate damaging effect, antitumor and treatment disease such as the inflammation etc. of smoking to human body.
Ganoderma is the traditional medicinal fungi of China, belongs to Basidiomycetes.For thousands of years, Ganoderma is owing to its good curative effect is described as " Herba mesonae chinensis ".Put down in writing " obey for a long time body light, life lengthening " in the book on Chinese herbal medicine.The modern science and technology result of study shows: this special effect of Ganoderma mainly gives the credit to wherein contained ganoderan and Ganodenic acid.
Ganoderan is that a big class is with β-(1,3) and polysaccharide or heteropolysaccharide macromolecular substances that β-(1,4) key is formed by connecting, one of its main component is β-(1,3)-and the D-glucosan, it is regular configuration promoter of human body macrophage effective chemical and activator.Also have in the surface receptor of human body macrophage-serial β-(1,3)-D-glucan structure, they can be used to accept the poly-polysaccharide in this micromolecular Portugal and are activated.Because macrophage belongs to the immune system of human body, it is movable that activated macrophage then begins immunity, generate cytokinesis element, interferon etc., and can cause the lymphocytic asexual propagation of T-, itself also can be used as cell antigen, so ganoderan also can be used for heal wound, anti-inflammatory and antitumor.Some cell of Langerhan in the human body also is the residue part of macrophage, can be activated by ganoderan and produce the cytokinesis element, thereby can wound healing and antibiotic, can prevent some malignant tumor such as basic cell tumour (basal cell cancer) and squamous cell tumor (squamous cellcancer) etc.
Ganodenic acid is a class triterpenoid compound, can play functions such as protecting liver and expelling toxin, blood pressure lowering, blood fat reducing when acting on inside of human body; Act on externally, can play the effect of antibacterial anti-inflammatory, simultaneously it can also with the ganoderan synergism, ganoderan is had potentiation.
Present existing Ganoderma series products is to be raw material with Ganoderma sporophore or its extract mostly, and dosage form is oral liquid or powder mostly, and extraction process is loaded down with trivial details, and cost is higher.The uncomfortable zygote of its dosage form is treated in the oral cavity or respiratory tract disease.A kind of technology for preparing lucid ganoderma buccal tablets has been proposed in the Chinese patent 95111597.9, but its used Ganoderma raw material is the ethanol extract of Ganoderma sporophore, and its cost of material and extraction cost all are higher than the cost with Ganderma lucidum fermentation liquid (or full powder) itself or the ganoderma active thing that extracts from above-mentioned material; And pure lixiviate technology can not extract Ganodenic acid and ganoderan in the sporophore fully, effectively.
The objective of the invention is to the ganoderma active thing is feedstock production lamellar health product or medicine, in order to improve immunity, defying age and to alleviate damaging effect, antitumor and the treatment disease etc. of smoking to human body.
The measure of taking is to make tablet with Ganoderma raw material 1-98% and other compositions 2-50% for achieving the above object.
Described Ganoderma raw material is for Ganderma lucidum fermentation liquid or full powder or the ganoderma active thing that extracts from above-mentioned material.
Described other compositions are various food additive, drug additive or medicinal ingredient and health-care components.
Described various food additive refers to sweeting agent, vitamin, aroma compound etc.
Described medicinal ingredient and health-care components refer to medicine and other medicinal herb components such as Radix Ginseng, Lentinus Edodes and the fungus polysaccharide except that ganoderan of other treatment disease in mouth or respiratory tract disease.
Another its composition that is characterised in that of the present invention is:
The Ganderma lucidum full powder 82-95% that ferments
Compound vitamin B 2-4%
Sweeting agent is an amount of
Fructus Citri tangerinae essence 0.5%
The filler surplus
Above-mentioned each thing is fully ground and be pressed into lamellar after the mixing according to a conventional method, make the lucid ganoderma buccal tablets that disease in mouth comprises that the esophagus disease patient uses.
Perhaps:
Ganderma lucidum fermentation activity component extract 70-90%
Lentinan 10-20%
Fructus Citri tangerinae essence 0.3-0.7%
The filler surplus
Above-mentioned each thing is fully ground and be pressed into lamellar after the mixing according to a conventional method, make chemotherapy and rise the Ganoderma tablet that white patient uses
Perhaps:
The Ganderma lucidum full powder 85-97% that ferments
Radix Glycyrrhizae 1-3%
Herba Menthae essence 0.3-0.7%
The filler surplus
Grind and be pressed into lamellar after above-mentioned each thing fully mixed according to a conventional method, make and alleviate harmfulness of smoking and treat bronchitic Ganoderma tablet.
Perhaps:
Ganderma lucidum fermentation activity component extract 50-70%
Lentinan 30-40%
Vitamin C 1-3%
Fructus Citri tangerinae essence 0.3-0.7%
The filler surplus
Grind and be pressed into lamellar after technology is fully mixed routinely with above-mentioned each thing, make and add deep sleep, orectic Ganoderma tablet.
Perhaps:
Ganderma lucidum fermentation activity component extract 50-70%
Lentinan 30-40%
Calcium lactate 0.5-1.5%
Vitamin A, D preparation 0.5-1.5%
Cream flavour 0.5
The filler surplus
Above-mentioned each thing is fully ground and be pressed into lamellar after the mixing according to a conventional method, make the Ganoderma tablet of child's appetite stimulator, raising immunity.
The unit of indication of the present invention is percetage by weight.
Advantage of the present invention is: with Ganderma lucidum fermentation liquid (or full powder) or the ganoderma active thing that extracts from above-mentioned material is raw material, and the active components of glossy ganoderma in the fermented product can farthest be saved and utilize to this composition from damage.With this raw material directly or cooperate other composition to make tablet, by buccal or swallow with reach make the user improve immunity, defying age and alleviate smoking to the damaging effect of human body, improve the resistance of tumor and make the cancer patient rise white, as to treat some disease such as respiratory inflammation etc. purpose.But not only can swallow but also buccal, can be mixed with the product of different flavor and heterogeneity, satisfy various ages and various health status crowds' needs.Especially during buccal, its medicine is slowly swallowed, and through throat, is directly had an effect in the throat, and the treatment of some respiratory tract diseases is had effect preferably.
The present invention is raw materials used to be: Ganderma lucidum fermentation liquid (or full powder) or the ganoderma active thing that extracts from above-mentioned material, food, drug additive or medicinal ingredient and health-care components such as sweeting agent, essence, filler or the like.
Below the present invention is carried out the description of embodiment, embodiment is as follows:
Embodiment 1: the lucid ganoderma buccal tablets that comprises the esophagus disease patient in order to disease in mouth
Form content (%)
The Ganderma lucidum full powder 92 that ferments
Compound vitamin B 3
Sweeting agent is an amount of
Fructus Citri tangerinae essence 0.5
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 2: the lucid ganoderma buccal tablets that comprises the esophagus disease patient in order to disease in mouth
Form content (%)
The Ganderma lucidum full powder 87 that ferments
Compound vitamin B 2
Sweeting agent is an amount of
Fructus Citri tangerinae essence 0.7
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 3: the lucid ganoderma buccal tablets that comprises the esophagus disease patient in order to disease in mouth
Form content (%)
The Ganderma lucidum full powder 97 that ferments
Compound vitamin B 4
Sweeting agent is an amount of
Fructus Citri tangerinae essence 0.3
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 4: the Ganoderma tablet that rises white patient in order to chemotherapy
Form content (%)
Ganderma lucidum fermentation activity component extract 70
Lentinan 20
Fructus Citri tangerinae essence 0.7
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 5: the Ganoderma tablet that rises white patient in order to chemotherapy
Form content (%)
Ganderma lucidum fermentation activity component extract 80
Lentinan 15
Fructus Citri tangerinae essence 0.5
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 6: the Ganoderma tablet that rises white patient in order to chemotherapy
Form content (%)
Ganderma lucidum fermentation activity component extract 90
Lentinan 25
Fructus Citri tangerinae essence 0.3
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 7: in order to alleviate harmfulness of smoking and to treat bronchitic Ganoderma tablet
Form content (%)
The Ganderma lucidum full powder 95 that ferments
Radix Glycyrrhizae 2
Herba Menthae essence 0.5
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 8: in order to alleviate harmfulness of smoking and to treat bronchitic Ganoderma tablet
Form content (%)
The Ganderma lucidum full powder 93 that ferments
Radix Glycyrrhizae 3
Herba Menthae essence 0.3
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 9: in order to alleviate harmfulness of smoking and to treat bronchitic Ganoderma tablet
Form content (%)
The Ganderma lucidum full powder 97 that ferments
Radix Glycyrrhizae 1
Herba Menthae essence 0.7
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 10: in order to add deep sleep, orectic Ganoderma tablet
Form content (%)
Ganderma lucidum fermentation activity component extract 60
Lentinan 35
Vitamin C 2
Fructus Citri tangerinae essence 0.5
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 11: in order to add deep sleep, orectic Ganoderma tablet
Form content (%)
Ganderma lucidum fermentation activity component extract 50
Lentinan 45
Vitamin C 1
Fructus Citri tangerinae essence 0.3
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 12: in order to add deep sleep, orectic Ganoderma tablet
Form content (%)
Ganderma lucidum fermentation activity component extract 70
Lentinan 25
Vitamin C 2
Fructus Citri tangerinae essence 0.5
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 13: in order to the Ganoderma tablet of child's appetite stimulator, raising immunity
Form content (%)
Ganderma lucidum fermentation activity component extract 60
Lentinan 35
Calcium lactate 1
Vitamin A, D preparation 1
Cream flavour 0.5
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 14: in order to the Ganoderma tablet of child's appetite stimulator, raising immunity
Form content (%)
Ganderma lucidum fermentation activity component extract 50
Lentinan 40
Calcium lactate 0.5
Vitamin A, D preparation 1.5
Cream flavour 0.3
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Embodiment 15: in order to the Ganoderma tablet of child's appetite stimulator, raising immunity
Form content (%)
Ganderma lucidum fermentation activity component extract 70
Lentinan 30
Calcium lactate 1.5
Vitamin A, D preparation 0.5
Cream flavour 0.7
The filler surplus
Above-mentioned each thing is fully ground and is pressed into lamellar after the mixing according to a conventional method.
Claims (6)
1. the lamellar health product or the medicine that contain the ganoderma active thing, it is characterized in that, the composition of these lamellar health product or medicine contains: Ganderma lucidum fermentation activity component extract 50～90%, lentinan 15～45%, flavoring agent 0.3～0.7%, vitamin 0.5～2% and an amount of filler, unit are percetage by weight.
2. according to described lamellar health product of claim 1 or medicine, it is characterized in that: also contain 0.5～1.5% calcium lactate in these lamellar health product or medicine, unit is a percetage by weight.
3, according to described lamellar health product of claim 1 or medicine, it is characterized in that: flavoring agent is Fructus Citri tangerinae essence or cream flavour.
4, according to described lamellar health product of claim 1 or medicine, it is characterized in that: vitamin is a vitamin C, or vitamin A and D.
5. according to claim 1 or 2 or 3 or 4 described lamellar health product or medicines, it is characterized in that,
Ganderma lucidum fermentation activity component extract 50-70%
Lentinan 30-40%
Calcium lactate 0.5-1.5%
VitaminsAandDpreparation 0.5-1.5%
Cream flavour 0.5
The filler surplus
6. lamellar health product or medicine is characterized in that the composition of these lamellar health product or medicine is:
Ganderma lucidum fermentation activity component extract 50-70%
Lentinan 30-40%
Vitamin C 1-3%
Fructus Citri tangerinae essence 0.3-0.7%
The filler surplus
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00112358 CN1247211C (en) | 2000-06-21 | 2000-06-21 | Health-care or medicinal tablet containing active ganoderma extract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00112358 CN1247211C (en) | 2000-06-21 | 2000-06-21 | Health-care or medicinal tablet containing active ganoderma extract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1291510A CN1291510A (en) | 2001-04-18 |
| CN1247211C true CN1247211C (en) | 2006-03-29 |
Family
ID=4582221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00112358 Expired - Fee Related CN1247211C (en) | 2000-06-21 | 2000-06-21 | Health-care or medicinal tablet containing active ganoderma extract |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1247211C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100369616C (en) * | 2006-03-23 | 2008-02-20 | 成海荣 | Glossy ganoderma essence liquid and its usage |
| CN102578349A (en) * | 2012-02-07 | 2012-07-18 | 何松庆 | Pressed candies added with fresh glossy ganoderma full-juice powder |
| CN106562404A (en) * | 2016-10-30 | 2017-04-19 | 福建容益菌业科技研发有限公司 | Sparassis crispa lozenges |
-
2000
- 2000-06-21 CN CN 00112358 patent/CN1247211C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1291510A (en) | 2001-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1875996A (en) | A composition having anti-oxygenation function | |
| CN1255376A (en) | Method of enhancing crude drugs anti-tumour activity | |
| CN1706280A (en) | Health food capable of raising immunity and its production process | |
| CN1620920A (en) | Composite fungi amylose nutrient | |
| CN1067538C (en) | Health-care powder | |
| CN1247211C (en) | Health-care or medicinal tablet containing active ganoderma extract | |
| CN1883286A (en) | A tea milk and method for preparing same | |
| CN1813819A (en) | Hedgehog hydnum fruiting body or hyphostroma and culture extract and formulation and preparing method | |
| CN1246011C (en) | Multi-function health care food and application thereof | |
| CN1253159C (en) | Health product of compound propolis and preparing method | |
| CN101041024A (en) | Medicinal composition for treating tuberculosis and its preparing process | |
| CN1258994C (en) | Fruit vinegar chewing tablet food and its preparation method | |
| CN1628662A (en) | Medicine with abirritation | |
| CN1824086A (en) | Health protection capsule | |
| CN1869208A (en) | Preparation of caterpillar fungus SOD and health-care product containing caterpillar fungus SOD | |
| CN1853656A (en) | Fermentation composition having immunomodulating effect | |
| CN1166402C (en) | Composite Chinese medicine with health care function | |
| CN1319431A (en) | Method for improving antitumor activity of amarogentin substance and its composition and evaluation method | |
| CN1283300C (en) | Chinese traditional medicine composition for treating diabetes and preparation method thereof | |
| CN101062314A (en) | Medicine for curing gout and its preparing method | |
| CN1685971A (en) | Body building nutrient | |
| CN1173640C (en) | Nutritive health-care food | |
| CN1184901C (en) | Health-care Zaozhishen food | |
| CN1498626A (en) | Application of hyaluronic acid in raising immunity of human body and improving symptom of lacking immunity | |
| CN1224418C (en) | Biological preparation containing marine active substance and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: NONE WUXI FEILING BIOLOGY TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHANG KECHANG Effective date: 20021218 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20021218 Address after: 214101 Bamboo Road, Xishan Economic Development Zone, Wuxi, Jiangsu Applicant after: Wuxi Feiling Biotech. Co., Ltd. Address before: 214036 Jiangsu city of Wuxi Province River Road No. 170 Applicant before: Zhang Kechang |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG KECHANG Free format text: FORMER OWNER: NONE WUXI FEILING BIOLOGY TECHNOLOGY CO., LTD. Effective date: 20060728 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20060728 Address after: 214036 Jiangsu city of Wuxi Province River Road No. 170 Jiangnan University P.O. Box 114 Patentee after: Zhang Kechang Address before: Bamboo Road, Xishan Economic Development Zone, Wuxi, Jiangsu Patentee before: Wuxi Feiling Biotech. Co., Ltd. |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |